A Drug Commonly Used On Alzheimer's Patients May Also Temporarily Delay the Onset of the Disease

Albert Kaman has been diagnosed with mild cognitive impairment, a memory disorder that often leads to Alzheimer's Disease. However, a new study on a drug commonly used on Alzheimer's patients may help Kaman and millions of other people suffering from a memory disorder.

The drug trial at Mayo Clinic involved 769 people. It concluded Vitamin E, widely discussed as a possible way to prevent Alzheimer's was not effective. However, Dr. Ronald Peterson, Director of the Mayo Clinic's Alzheimer's Disease Center, says those who took aricept, the most widely used Alzheimer's drug, were able to delay onset of the disease for six to 18 months.

"This study opens the door then for us to develop other treatment alternatives to be developed to intervene at this early stage in the disease."

Dr. Peterson says this is important because the number of Alzheimer's cases will triple to 16 million as baby boomers get older and place great burdens not just on the families of victims, but on the nation's entire health care system.